We are live on
!
Find out more
LPC
Lion Point Capital Portfolio holdings
AUM
$16.7M
1-Year Est. Return
119.35%
This Fund
S&P 500
This Quarter
Est. Return
-4.4%
1 Year Est. Return
+119.35%
3 Year Est. Return
+204.43%
5 Year Est. Return
+220.32%
10 Year Est. Return
+1,396.08%
AUM
$224M
AUM Growth
+$3.13M
(+1.4%)
Cap. Flow
+$13.8M
Cap. Flow
% of AUM
6.13%
Top 10 Holdings %
Top 10 Hldgs %
93.45%
Holding
37
New
6
Increased
4
Reduced
4
Closed
6
Top Buys
| 1 |
Travere Therapeutics
TVTX
|
+$1.1M |
| 2 |
AVDL
Avadel Pharmaceuticals
AVDL
|
+$1.07M |
| 3 |
Humacyte
HUMA
|
+$778K |
| 4 |
Replimune Group
REPL
|
+$687K |
| 5 |
Insmed
INSM
|
+$457K |
Top Sells
| 1 |
Chord Energy
CHRD
|
+$15.7M |
| 2 |
Ardelyx
ARDX
|
+$1.37M |
| 3 |
TSVT
2seventy bio
TSVT
|
+$1.13M |
| 4 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
+$933K |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$761K |
Sector Composition
| 1 | Technology | 28.16% |
| 2 | Healthcare | 10.07% |
| 3 | Consumer Discretionary | 1.42% |
| 4 | Energy | 1.05% |
| 5 | Communication Services | 0.01% |
Similar funds
PA
PA
SR
SCTC
SRA
CP
B
CVV